Flurotest Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CALGARY, AB, May 10, 2021 /PRNewswire/ - 
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary
FluroTest or
The Company), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announces the next phase of its ongoing clinical trials with its trial partner Toolbox Medical Innovations ( Toolbox ).
The Company is pleased to report that approximately 600 volunteer participants, including both symptomatic and asymptomatic individuals, are being identified from six clinical site locations across California, Texas, Colorado, Rhode Island and Florida (with two sites) to determine performance detection results alongside a comparator RT-PCR assay. The data collected from this and the upcoming pilot program with California-based Total Testing Solutions (previously announced in the Company s news release dated May 3, 2021) will be used to support submissions for Emergency Use Autho ....

United States , Rhode Island , Melina Cimler , Flurotest Diagnostics Systems Ltd , Corporation Annual Information Form , Drug Administration , Biden Administration , University Of Calgary , Health Canada , Founder Of Pandiadx , Flurotest Diagnostic Systems Ltd , Flurotech Ltd , Testing Solutions , Test Diagnostics Systems , Toolbox Medical Innovations , California Based Total Testing Solutions , Emergency Use Authorization , Interim Order , Bill Phelan , Flurotest Diagnostics , Flurotest Diagnostics Systems , Annual Information Form , ஒன்றுபட்டது மாநிலங்களில் , ரோட் தீவு , நிறுவனம் ஆண்டு தகவல் வடிவம் , பல்கலைக்கழகம் ஆஃப் கல்கரி ,